TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Are Pot Stocks Drying Up?
Investing
Marijuana Stocks: Is the Recent Dip a Buying Opportunity?
Investing
Why Canopy Growth Corp. Has Been More Resilient This Time Around
Investing
Reality Bites As Canadian Pot Stocks Plummet
Investing
Is This Company Going to Be the “Starbucks” of Pot?
Investing
Should Investors Stay Away from Aphria Inc.?
Top TSX Stocks
Top Stocks for April
Dividend Stocks
2 Strategies to Beat the Market Over the Long Term
Investing
A New Cannabis IPO Could Serve as a Barometer for a Volatile Market
Investing
Is Aphria Inc. Still Harbouring U.S. Expansion Ambitions?
Investing
Aurora Cannabis Inc. Is Down 10% in the Past Month: Is Now a Good Time to Buy?